Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake
- PMID: 32227540
- DOI: 10.1002/chem.202001115
Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake
Abstract
The use of multimeric ligands is considered as a promising strategy to improve tumor targeting for diagnosis and therapy. Herein, tetrameric RGD (Arg-Gly-Asp) peptidomimetics were designed to target αv β3 integrin-expressing tumor cells. These compounds were prepared by an oxime chemoselective assembly of cyclo(DKP-RGD) ligands and a cyclodecapeptide scaffold, which allows a tetrameric presentation. The resulting tetrameric RGD peptidomimetics were shown to improve αv β3 integrin binding compared with the monomeric form. Interestingly, these compounds were also able to enhance tumor cell endocytosis in the same way as tetrameric RGD peptides. Altogether, the results show the potential of the tetrameric cyclo(DKP-RGD) ligands for in vivo imaging and drug delivery.
Keywords: RGD peptide; cell targeting; integrins; multivalency; peptidomimetics.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin αV β3.Chemistry. 2017 Oct 17;23(58):14410-14415. doi: 10.1002/chem.201703093. Epub 2017 Sep 6. Chemistry. 2017. PMID: 28816404 Free PMC article.
-
Cyclic RGD and isoDGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic (cis-β-ACPC) Scaffolds.Molecules. 2020 Dec 16;25(24):5966. doi: 10.3390/molecules25245966. Molecules. 2020. PMID: 33339382 Free PMC article.
-
High-Affinity "Click" RGD Peptidomimetics as Radiolabeled Probes for Imaging αv β3 Integrin.ChemMedChem. 2017 Jul 20;12(14):1142-1151. doi: 10.1002/cmdc.201700328. Epub 2017 Jul 3. ChemMedChem. 2017. PMID: 28608961
-
Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer.Chembiochem. 2021 Apr 6;22(7):1151-1160. doi: 10.1002/cbic.202000626. Epub 2020 Nov 27. Chembiochem. 2021. PMID: 33140906 Review.
-
αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology.Curr Top Med Chem. 2016;16(3):314-29. doi: 10.2174/1568026615666150701114343. Curr Top Med Chem. 2016. PMID: 26126915 Review.
Cited by
-
Discovery, affinity maturation and multimerization of small molecule ligands against human tyrosinase and tyrosinase-related protein 1.RSC Med Chem. 2020 Nov 13;12(3):363-369. doi: 10.1039/d0md00310g. RSC Med Chem. 2020. PMID: 34041485 Free PMC article.
-
Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment.Int J Nanomedicine. 2024 Jan 23;19:743-758. doi: 10.2147/IJN.S440619. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38283199 Free PMC article.
-
Non-Canonical Amino Acids as Building Blocks for Peptidomimetics: Structure, Function, and Applications.Biomolecules. 2023 Jun 12;13(6):981. doi: 10.3390/biom13060981. Biomolecules. 2023. PMID: 37371561 Free PMC article. Review.
-
In Situ Targeting RGD-Modified Cyclodextrin Inclusion Complex/Hydrogel Hybrid System for Enhanced Glioblastoma Therapy.Pharmaceutics. 2025 Jul 20;17(7):938. doi: 10.3390/pharmaceutics17070938. Pharmaceutics. 2025. PMID: 40733145 Free PMC article.
-
Prospective study of 99mTc-3PRGD2 SPECT/CT diagnosing metastatic lymph nodes in esophageal squamous cell carcinoma.Thorac Cancer. 2024 Sep;15(27):1958-1967. doi: 10.1111/1759-7714.15421. Epub 2024 Aug 14. Thorac Cancer. 2024. PMID: 39140206 Free PMC article.
References
-
- M. Mammen, S. K. Choi, M. Whitesides, Angew. Chem. Int. Ed. 1998, 37, 2754-2794;
-
- Angew. Chem. 1998, 110, 2908-2953.
-
- None
-
- A. Barnard, D. K. Smith, Angew. Chem. Int. Ed. 2012, 51, 6572-6581;
-
- Angew. Chem. 2012, 124, 6676-6685;
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources